The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.

The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and UnitedHealth Group Inc., alleging that they artificially pumped up prices of insulin ...

Tard's bid to acquire Seven & i faces significant hurdles. Find out why I think ANCTF stock is a buy while SVNDY stock is a ...

In the latest market close, CVS Health (CVS) reached $58.40, with a -0.03% movement compared to the previous day. The stock trailed the S&P 500, which registered a daily gain of 1.7%. Meanwhile, the ...

CVS Health Corp (CVS) stock saw a modest uptick, ending the day at $58.42 which represents a slight increase of $0.59 or 1.02% from the prior close of $57.83. The stock opened at $57.88 and touched a ...

While we acknowledge the potential of CVS as an investment, our conviction lies in the belief that AI stocks hold great ...

The highly-touted team at Andean Silver has attracted A$25 million in new investment to their Chile venture, with the pricing ...

CVS Health Corp. closed $24.83 short of its 52-week high ($83.25), which the company reached on January 8th.

Portfolio manager Scott Rosenthal believes Big Tech valuations are untenable. He shares 4 bargain stocks that the market is ...